This observation, which needs to be validated in a larger cohort, might suggest the relevance of studying TMM as a biomarker in high‐grade pediatric osteosarcomas to reassign ALT‐positive good responders as candidates for alternative adjuvant therapy after surgery. Here, GPT is linked to osteosarcoma.